TP53 and embryonal rhabdomyosarcoma: ERMS is of course also a potential manifestation of the Li–Fraumeni syndrome [51] and young presentation (<2 years old), particularly with ERMS, should prompt an in-depth investigation of family cancer history and germline TP53 mutational analysis.